Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Sildenafil Persistent Pulmonary Hypertension of the Newborn (PPHN) follow up study
To monitor the developmental progress of PPHN patients treated with sildenafil in study A1481276, 12 and 24 months after completion of sildenafil treatment.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Ltd, Ramsgate Road, Sandwich, Kent. UK
Update Il y a 4 ans
A PHASE 2A, DOUBLE BLIND (3RD PARTY OPEN), 4 WAY CROSS-OVER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE PHARMACOKINETICS, SAFETY, TOLERATION AND EFFICACY OF SINGLE INHALED DOSES OF PF-00610355 IN MODERATE COPD PATIENTS
• To characterize the single dose pharmacokinetics of inhaled PF-00610355 in COPD patients. • To evaluate the safety & toleration of single inhaled doses of PF-00610355 in COPD patients.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Pfizer A4061034 : Essai de phase 2 randomisé, comparant l’efficacité et la tolérance d’une chimiothérapie de type FOLFOX ou FOLFIRI associé au bévacizumab ou à l’axitinib, en traitement de 2ème ligne, chez des patients ayant un cancer colorectal métastatique. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer si l’association d’une chimiothérapie de type FOLFOX ou FOLFIRI à l’axitinib est plus efficace que la même chimiothérapie associée au bévacizumab, chez des patien...
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A clinical trial to assess a novel medicine in the treatment of patients with moderately to severely active rheumatoid arthritis
To compare the efficacy of 5 mg BID of tofacitinib (with and without background MTX) to adalimumab with MTX as measured by American College of Rheumatology 50% improvement (ACR50) response rates at Mo...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
A study to test pregabalin in the treatment of patients with painful diabetic peripheral neuropathy and pain on walking
There are two co-primary objectives for this study. In patients with painful DPN, to evaluate the efficacy of pregabalin compared to placebo in: 1. The reduction in DPN pain; and 2. The reduction i...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
PFIZER A8081007 : Essai de phase 3 randomisé comparant l’efficacité et la tolérance du PF-02341066 à la chimiothérapie de référence par docétaxel ou pémétrexed chez des patients ayant un cancer du poumon non à petites cellules avancé avec translocation ou inversion au niveau du gène ALK (anaplastic lymphoma kinase). [essai clos aux inclusions]
L’objectif de cet essai est de comparer l’efficacité et la tolérance du PF-02341066 à la chimiothérapie de référence par docétaxel ou pémétrexed chez des patients ayant un cancer du poumon non à petit...
Country
France
organs
Poumon, type non à petites cellules
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pfizer Global Research & Development
Update Il y a 4 ans
A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders
Main objective : • To evaluate under open-label conditions the long-term safety and tolerability of pregabalin in doses ranging from 150 to 600 mg/day.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Pfizer A6181111 : Essai de phase 3 randomisé en double aveugle, évaluant l’efficacité du sunitinib (Sutent®), chez des patients ayant une tumeur avancée ou métastatique des cellules des îlots pancréatiques de langerhans. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’efficacité d'un traitement par sunitinib chez patients ayant une tumeur avancée ou métastatique des cellules des îlots pancréatiques de langerhans. Les patient...
Country
France
organs
Pancréas
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pfizer Inc 235 East 42nd Street, New York, NY10017 US
Update Il y a 4 ans
A clinical trial to determine if the investigational MnB vaccine works when 2 or 3 doses of the vaccine is given to adolescents
Co-Primary Objectives: To assess the immune response as measured by serum bactericidal assay performed with MnB strains expressing LP2086 subfamily A and B proteins, measured 1 month after the thi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
A 12-week, open label, multicentre study assessing the efficcay and of Donepezil in patients discontinuing treatment with Memantine monotherapy
To evaluate the efficacy of donepezil on cognition (MMSE) in patients who are currently being treated with memantine, and are switched to donepezil because treatment with memantine is lacking efficacy...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
5
6
7
8
9
10
11
12
13
14
Next